Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double …

…, WH Boehncke, R Casasola, T Crook… - The lancet …, 2021 - thelancet.com
Background The European Organisation for Research and Treatment of Cancer (EORTC)
1325/KEYNOTE-054 trial assessed pembrolizumab versus placebo in patients with resected …

Arginine deprivation with pegylated arginine deiminase in patients with argininosuccinate synthetase 1–deficient malignant pleural mesothelioma: a randomized …

…, M Tomsa, C Lawrence, P Schmid, T Crook… - JAMA …, 2017 - jamanetwork.com
Importance Preclinical studies show that arginine deprivation is synthetically lethal in
argininosuccinate synthetase 1 (ASS1)-negative cancers, including mesothelioma. The role of the …

[HTML][HTML] Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors

…, G Anichini, AG Tzakos, T Crook… - The Journal of …, 2022 - Am Soc Clin Investig
New approaches for the management of glioblastoma (GBM) are an urgent and unmet clinical
need. Here, we illustrate that the efficacy of radiotherapy for GBM is strikingly potentiated …

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind …

…, E Richtig, S Matkovic, T Inozume, T Crook… - The lancet …, 2021 - thelancet.com
Background The European Organisation for Research and Treatment of Cancer (EORTC)
1325-MG/KEYNOTE-054 trial in patients with resected, high-risk stage III melanoma …

[HTML][HTML] Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis

…, L Lattanzio, G Sauter, CL Nigro, T Crook… - The American journal of …, 2010 - Elsevier
Reelin is a secreted, signaling protein associated with neuronal cell positioning and migration.
Recently, reelin was found to be epigenetically silenced in gastric and pancreatic cancers …

[HTML][HTML] Accurate screening for early-stage breast cancer by detection and profiling of circulating tumor cells

T Crook, R Leonard, K Mokbel, A Thompson, M Michell… - Cancers, 2022 - mdpi.com
Simple Summary Detection of breast cancer in the early stages is associated with higher
cure rates and better survival, and also requires fewer intensive treatments. Current breast …

A phase I study of pegylated arginine deiminase (pegargiminase), cisplatin, and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma

…, K Smith, BW Wu, JS Bomalaski, T Crook… - Clinical Cancer …, 2019 - AACR
Purpose: Patients with recurrent high-grade gliomas (HGG) are usually managed with alkylating
chemotherapy ± bevacizumab. However, prognosis remains very poor. Preclinically, we …

[HTML][HTML] Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer

…, CM Lewis, IM Leigh, A Storey, T Crook… - Journal of investigative …, 2002 - Elsevier
Upregulation of p53 protein induces either growth arrest or apoptosis in response to cellular
injury This is signaled from a highly conserved p53 domain between codons 64 and 92, …

Circulating ensembles of tumor‐associated cells: a redoubtable new systemic hallmark of cancer

D Akolkar, D Patil, T Crook, S Limaye… - … Journal of cancer, 2020 - Wiley Online Library
Circulating ensembles of tumor‐associated cells (C‐ETACs) which comprise tumor emboli,
immune cells and fibroblasts pose well‐recognized risks of thrombosis and aggressive …

Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable “click” oxime bond tethers and preclinical evaluation against prostate cancer

…, N Sayyad, A Kougioumtzi, N Syed, T Crook… - European journal of …, 2021 - Elsevier
Peptide-drug conjugates (PDCs) are gaining considerable attention as anti-neoplastic
agents. However, their development is often laborious and time-consuming. Herein, we have …